While the approval of Epidiolex will certainly lay the foundation for a challenge to the DEA scheduling of the underlying plant from which CBD is derived or even CBD itself, the DEA can schedule it differently from cannabis itself. GW Pharma expects the drug, if approved, to be Schedule 4, similar to many ...
from Google Alert - cbd hemp https://ift.tt/2vJbyRu
via IFTTT ** Interested in building your own business with hemp? Go now! https://ift.tt/SbMGZP **
No comments:
Post a Comment